These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 32868244)

  • 1. Macular pigment optical density and visual quality of life.
    Wilson MR; Sandberg KA; Foutch BK
    J Optom; 2021; 14(1):92-99. PubMed ID: 32868244
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of Macular Pigment Optical Density in Glaucoma Patients and Healthy Subjects - A Prospective Diagnostic Study.
    Bruns Y; Junker B; Boehringer D; Framme C; Pielen A
    Clin Ophthalmol; 2020; 14():1011-1017. PubMed ID: 32308361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Macular pigment spatial distribution effects on glare disability.
    Putnam CM; Bassi CJ
    J Optom; 2015; 8(4):258-65. PubMed ID: 25697374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlations between internal and external ocular factors and macular pigment optical density.
    Tudosescu R; Alexandrescu CM; Istrate SL; Vrapciu AD; Ciuluvică RC; Voinea L
    Rom J Ophthalmol; 2018; 62(1):42-47. PubMed ID: 29796433
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Macular pigment is associated with glare-affected visual function and central visual field loss in glaucoma.
    Siah WF; O'Brien C; Loughman JJ
    Br J Ophthalmol; 2018 Jul; 102(7):929-935. PubMed ID: 28982957
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in Macular Pigment Optical Density and Serum Lutein Concentration in Japanese Subjects Taking Two Different Lutein Supplements.
    Obana A; Tanito M; Gohto Y; Okazaki S; Gellermann W; Bernstein PS
    PLoS One; 2015; 10(10):e0139257. PubMed ID: 26451726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical Effects of Dietary Supplementation of Lutein with High Bio-Accessibility on Macular Pigment Optical Density and Contrast Sensitivity: A Randomized Double-Blind Placebo-Controlled Parallel-Group Comparison Trial.
    Machida N; Kosehira M; Kitaichi N
    Nutrients; 2020 Sep; 12(10):. PubMed ID: 32998324
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomized, double-blind, placebo-controlled study of zeaxanthin and visual function in patients with atrophic age-related macular degeneration: the Zeaxanthin and Visual Function Study (ZVF) FDA IND #78, 973.
    Richer SP; Stiles W; Graham-Hoffman K; Levin M; Ruskin D; Wrobel J; Park DW; Thomas C
    Optometry; 2011 Nov; 82(11):667-680.e6. PubMed ID: 22027699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Macular pigment levels do not influence C-Quant retinal straylight estimates in young Caucasians.
    Beirne RO
    Clin Exp Optom; 2014 Mar; 97(2):171-4. PubMed ID: 23980706
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of macular pigment on the sensitivity to discomfort glare from daylight.
    Jain S; Wienold J; Eandi C; Gisselbaek S; Kawasaki A; Andersen M
    Sci Rep; 2023 Oct; 13(1):18551. PubMed ID: 37899478
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Color Perimetric Test to Evaluate Macular Pigment Density in Age-Related Macular Degeneration.
    Demirel S; Ozmert E; Batioglu F; Gedik-Oguz Y
    Optom Vis Sci; 2016 Jun; 93(6):632-9. PubMed ID: 26927521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Macular Pigment Optical Density in the Korean Population: a Cross Sectional Study.
    Hong IH; Jung WH; Lee JH; Chang IB
    J Korean Med Sci; 2020 Feb; 35(5):e30. PubMed ID: 32030919
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The relationship between macular pigment and visual performance.
    Loughman J; Akkali MC; Beatty S; Scanlon G; Davison PA; O'Dwyer V; Cantwell T; Major P; Stack J; Nolan JM
    Vision Res; 2010 Jun; 50(13):1249-56. PubMed ID: 20394766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A double-blind, placebo-controlled study on the effects of lutein and zeaxanthin on photostress recovery, glare disability, and chromatic contrast.
    Hammond BR; Fletcher LM; Roos F; Wittwer J; Schalch W
    Invest Ophthalmol Vis Sci; 2014 Dec; 55(12):8583-9. PubMed ID: 25468896
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Macular pigment density variation after supplementation of lutein and zeaxanthin using the Visucam
    Azar G; Quaranta-El Maftouhi M; Masella JJ; Mauget-Faÿsse M
    J Fr Ophtalmol; 2017 Apr; 40(4):303-313. PubMed ID: 28336284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The association between macular pigment optical density and visual function outcomes: a systematic review and meta-analysis.
    Johnson EJ; Avendano EE; Mohn ES; Raman G
    Eye (Lond); 2021 Jun; 35(6):1620-1628. PubMed ID: 32792595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dosage-dependent reduction of macular pigment optical density in female breast cancer patients receiving tamoxifen adjuvant therapy.
    Lim IL; Loo AVP; Subrayan V; Khang TF; See MH; Alip A; Taib NAM
    Breast; 2018 Jun; 39():117-122. PubMed ID: 29660599
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Macular pigment optical density change analysis in primary open-angle glaucoma and pseudoexfoliation glaucoma.
    Zeki Fikret C; Ucgun NI
    Int Ophthalmol; 2021 Jun; 41(6):2235-2240. PubMed ID: 33759069
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in macular pigment optical density after membrane peeling.
    Romano MR; Cennamo G; Grassi P; Sparnelli F; Allegrini D; Cennamo G
    PLoS One; 2018; 13(5):e0197034. PubMed ID: 29758035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lower Macular Pigment Optical Density in Foveal-Involved Glaucoma.
    Siah WF; Loughman J; O'Brien C
    Ophthalmology; 2015 Oct; 122(10):2029-37. PubMed ID: 26249732
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.